Clinical Update on the Evolving Role of B-Cell Targeting Therapies to Improve Outcomes in Patients with Generalized Myasthenia Gravis
Clinical Updates for Gene Silencing, RNA Interference Therapies for Transthyretin Amyloid Disease
Beyond Symptom Control: Targeting BAFF/APRIL Pathways in Generalized Myasthenia Gravis
The Role of Complement Pathway Inhibitors in the Management of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Improving Outcomes with Targeted FcRn Receptor Inhibition for the Full Spectrum of Patients with gMG
